文献速递产科

妊娠期糖尿病后立即产后糖尿病检测:一项随机对照试验

Diabetes Testing Immediately Postpartum After Gestational Diabetes Mellitus: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2026-03-12

本研究为实用型非盲随机对照试验,纳入104例妊娠期糖尿病(GDM)患者,1:1随机分为住院期间出院前口服葡萄糖耐量试验(OGTT)组和产后12周内门诊OGTT组。结果显示住院组产后糖尿病检测完成率显著更高(92.3% vs 26.9%,RR 3.43 [95%CI 2.18-5.40]),患者满意度更高,且前驱糖尿病或2型糖尿病诊断率有升高趋势(50.0% vs 21.4%,P=.05)。

要点

  • GDM患者出院前住院OGTT完成率92.3%,显著高于门诊组的26.9%(RR 3.43)。
  • 住院检测组患者满意度DTSQ中位评分35.0,高于门诊组的28.0(P<.001)。
  • 住院组前驱糖尿病或2型糖尿病诊断率50.0%,门诊组21.4%(P=.05)。

核心结论

  • GDM患者出院前住院糖尿病检测使产后葡萄糖检测完成率提高三倍以上,并提高患者满意度。

研究设计与样本

  • 实用型非盲随机对照试验(DIP研究),纳入104例产前保健并确诊GDM的个体,1:1随机分为住院出院前OGTT组(52例)和产后12周内门诊OGTT组(52例)。

主要发现

  • 住院组产后糖尿病检测完成率92.3%,门诊组26.9%,相对风险3.43(95%CI 2.18-5.40)。
  • 住院组DTSQ中位[IQR]评分35.0[31.0,36.0],门诊组28.0[24.0,32.0],P<.001。
  • 住院组前驱糖尿病或2型糖尿病诊断率50.0%,门诊组21.4%,P=.05。
  • 两组产后随访完成率均超过90%,人口学、未满足社会需求和临床特征无组间差异。

关键数值与推荐

  • 主要结局为产后12周内完成空腹2小时75-g OGTT。
  • 样本量104例基于估计基线检测率52%、治疗效应至少50%、80%把握度和双侧α=0.05计算。

临床怎么用

  • 对于GDM患者,可考虑在出院前提供住院产后糖尿病检测选项,以提高检测完成率和患者满意度。

局限性

  • 研究为非盲设计,样本量较小(104例),可能影响结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patient receipt of outpatient postpartum glucose testing after gestational diabetes mellitus (GDM) remains suboptimal. We conducted a randomized controlled trial (RCT) to determine whether the frequency of receiving a postpartum oral glucose tolerance test (OGTT) differed depending on whether the test was planned for the inpatient or outpatient setting. METHODS: DIP (Diabetes Testing Immediately Postpartum) was a pragmatic, nonblinded RCT. Participants were eligible if they received prenatal care and had a GDM diagnosis. After delivery, individuals were randomized in a 1:1 ratio to receive an OGTT either inpatient before delivery discharge (intervention) or outpatient within 12 weeks of birth (standard care). The primary outcome was completion of a fasting 2-hour 75-g OGTT by 12 weeks postpartum or less. Secondary outcomes included participant satisfaction per the adapted DTSQ (Diabetes Treatment Satisfaction Questionnaire) and diagnosis of prediabetes or type 2 diabetes. Based on an estimated baseline testing rate of 52% and a treatment effect of at least 50%, a sample size of 104 participants was required with 80% power and a two-sided α of 0.05. RESULTS: A total of 104 individuals with GDM were enrolled (52 intervention, 52 standard care). Demographics, unmet social needs, and clinical characteristics did not differ according to group assignment. Postpartum visit completion was more than 90% in both groups. The frequency of postpartum diabetes testing was significantly higher in the inpatient group compared with the outpatient group (92.3% vs 26.9%, relative risk 3.43 [95% CI, 2.18-5.40]), as was the median [IQR] score on the DTSQ (35.0 [31.0, 36.0] vs 28.0 [24.0, 32.0], P <.001). Prediabetes or type 2 diabetes was diagnosed among 50.0% in the inpatient group and 21.4% in the outpatient group ( P =.05). CONCLUSION: Diabetes testing before delivery discharge for individuals with GDM resulted in more than a threefold higher completion rate of postpartum glucose testing and greater patient satisfaction compared with outpatient testing. This RCT supports recent guidelines that encourage the option of inpatient postpartum diabetes testing before delivery discharge. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov , NCT05909046.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Field C, Grobman WA, Mast D, et al. Diabetes Testing Immediately Postpartum After Gestational Diabetes Mellitus: A Randomized Controlled Trial. Obstet Gynecol. 2026. PMID: 41842598. doi:10.1097/AOG.0000000000006236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。